DNMT3A and androgen insensitivity syndrome: To explore the potential mechanisms underlying the effect of DNMT3A mutation on neurological functional disability in AIS, the function of DNMT3A was inhibited using the small‐molecule compound SGI102722 or RG108 (10 mg/kg)23 in mice with transient middle cerebral artery occlusion (tMCAO; Figure 4A).